Más información sobre el libro
Although effective treatments for Non-alcoholic Steatohepatitis (NASH) are yet to be developed, several potentially promising treatment approaches are under investigation. This issue of Clinics in Liver Diseases presents the views of several internationally renowned NAFLD experts on the most up to date epidemiology, natural history, diagnosis, pathogenesis, and treatment of NAFLD. Additionally, this issue presents recent work on to the importance of NAFLD in children, as well as in the individuals who undergo weight reduction surgery. Experts discuss the role of new technologies, such as genomics and proteomics, in understanding NAFLD and developing new biomarkers, including fibrosis markers. Presents recent work on to the importance of NAFLD in children, as well as in the individuals who undergo weight reduction surgery.
Compra de libros
NASH, An Issue of Clinics in Liver Disease, Zobair M. Younossi
- Idioma
- Publicado en
- 2007
- product-detail.submit-box.info.binding
- (Tapa dura)
Métodos de pago
Nadie lo ha calificado todavía.
- Título
- NASH, An Issue of Clinics in Liver Disease
- Idioma
- Inglés
- Autores
- Zobair M. Younossi
- Editorial
- Saunders
- Publicado en
- 2007
- Formato
- Tapa dura
- Páginas
- 240
- ISBN10
- 141604289X
- ISBN13
- 9781416042891
- Serie
- Etiquetas
- No ficción, Salud & Medicina, Medicina
- Descripción
- Although effective treatments for Non-alcoholic Steatohepatitis (NASH) are yet to be developed, several potentially promising treatment approaches are under investigation. This issue of Clinics in Liver Diseases presents the views of several internationally renowned NAFLD experts on the most up to date epidemiology, natural history, diagnosis, pathogenesis, and treatment of NAFLD. Additionally, this issue presents recent work on to the importance of NAFLD in children, as well as in the individuals who undergo weight reduction surgery. Experts discuss the role of new technologies, such as genomics and proteomics, in understanding NAFLD and developing new biomarkers, including fibrosis markers. Presents recent work on to the importance of NAFLD in children, as well as in the individuals who undergo weight reduction surgery.